CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- 4/A Other disposition EVP, Chief Scientific Officer disposed of 0 shares (other)
- 4 Planned sale EVP Research sold 15,642 shares at an average $81.76 ($1,278,914)
- 4 Planned sale Director sold 5,000 shares at $82.72 ($413,589)
- 4 Planned sale Chief Executive Officer sold 29,430 shares at $85.79 ($2,524,820)
- 4 Planned sale EVP, Chief Scientific Officer sold 85,089 shares at an average $82.93 ($7,056,216)
- 4 Open-market sale EVP Research sold 6,179 shares at $82.93 ($512,446)
- 4 Open-market sale EVP, Chf Clinical Develop Ofcr sold 6,179 shares at $83.45 ($515,630)
- 4 Open-market sale EVP CLO & General Counsel sold 6,179 shares at $83.53 ($516,153)
- 4 Open-market sale Chief Executive Officer sold 62,970 shares at $82.72 ($5,208,979)
- 4 Open-market sale EVP, Finance & CFO sold 6,988 shares at $83.24 ($581,702)
- 4 Open-market sale EVP, Corp and Development Ops sold 6,179 shares at $83.03 ($513,048)
- 4 Open-market sale EVP, Chief Scientific Officer sold 5,885 shares at $82.95 ($488,141)
- 4 Open-market sale EVP, Chief Business Officer sold 5,296 shares at $82.96 ($439,364)
- 4 Planned sale EVP, Chief Human Resources Ofc sold 3,977 shares at $81.34 ($323,490)
- 4 Option exercise Director acquired 1,930 shares (option exercise)
- 4 Open-market sale EVP Research sold 9,933 shares at an average $75.34 ($748,383)
- 4 Open-market sale EVP, Chf Clinical Develop Ofcr sold 9,302 shares at $75.59 ($703,138)
- 4 Open-market sale EVP CLO & General Counsel sold 9,191 shares at $75.84 ($697,045)
- 4 Open-market sale Chief Executive Officer sold 44,034 shares at $74.82 ($3,294,624)
- 4/A Derivatives Options or other derivatives
Page 4 of 77 · 1,536 filings